Index of medicine substances

Rabbit anti-human lymphocyte immunoglobulin  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA04)

Rabeprazole  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Proton pump inhibitors (A02BC04)

Rabies vaccine inactivated  •  Antiinfectives for systemic use | Viral vaccines | Rabies vaccines (J07BG01)

Racecadotril  •  Alimentary tract and metabolism | Other antidiarrheals (A07XA04)

RADAMTS13  •  Blood and blood forming organs | Antithrombotic agents | Antithrombotic agents | Enzymes (B01AD13)

Radiopharmaceuticals  •  Various | Cardiovascular system | Technetium (99mtc) compounds (V09GA01)

Radiopharmaceuticals (18F fluorocholine chloride)  •  Various | Tumour detection | Other diagnostic radiopharmaceuticals for tumour detection (V09IX07)

Raloxifene  •  Genito urinary system and sex hormones | Other sex hormones and modulators of the genital system | Selective estrogen receptor modulators (G03XC01)

Raltegravir  •  Antiinfectives for systemic use | Direct acting antivirals | Integrase inhibitors (J05AJ01)

Ramipril  •  Cardiovascular system | Ace inhibitors, plain (C09AA05)

Ramipril + amlodipine  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and calcium channel blockers (C09BB07)

Ramipril + hydrochlorothiazide  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics (C09BA05)

Ramipril + indapamide  •  Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics (C09BA05)

Ramipril + nebivolol  •  ()

Ramucirumab  •  Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Vegf/vegfr (vascular endothelial growth factor) inhibitors (L01FG02)

Ranibizumab  •  Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents (S01LA04)

Ranitidine  •  Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | H2-receptor antagonists (A02BA02)

Ranolazine  •  Cardiovascular system | Other cardiac preparations (C01EB18)

Rasagiline  •  Nervous system | Dopaminergic agents | Monoamine oxidase B inhibitors (N04BD02)

Rasburicase  •  Various | All other therapeutic products | All other therapeutic products | Detoxifying agents for antineoplastic treatment (V03AF07)

Ravulizumab  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA43)

Red vine leaf extract  •  Cardiovascular system | Capillary stabilizing agents | Other capillary stabilizing agents (C05CXN2)

Refined dry extract from green tea leaves  •  Dermatologicals | Chemotherapeutics for topical use | Antivirals (D06BB12)

Regadenosone  •  Cardiovascular system | Other cardiac preparations (C01EB21)

Regdanvimab  •  Antiinfectives for systemic use | Immunoglobulins | Antiviral monoclonal antibodies (J06BD06)

Regorafenib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors (L01EX05)

Relugolix  •  Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Other hormone antagonists and related agents (L02BX04)

Relugolix + estradiol + norethisterone  •  Systemic hormonal preparations, excluding sex hormones and insulins | Hypothalamic hormones | Anti-gonadotropin-releasing hormones (H01CC54)

Remdesivir  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB16)

Remibrutinib  •  Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants (L04AA60)